Maravai Operating Cycle from 2010 to 2026
| MRVI Stock | USD 3.10 0.02 0.65% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 157.86 | Current Value 135.78 | Quarterly Volatility 27.86129816 |
Check Maravai Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maravai Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.8 M, Interest Expense of 36.5 M or Selling General Administrative of 113.9 M, as well as many indicators such as Price To Sales Ratio of 3.17, Dividend Yield of 0.0157 or PTB Ratio of 2.52. Maravai financial statements analysis is a perfect complement when working with Maravai Lifesciences Valuation or Volatility modules.
Maravai | Operating Cycle | Build AI portfolio with Maravai Stock |
The Operating Cycle trend for Maravai Lifesciences Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Maravai Lifesciences is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Maravai Lifesciences' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Maravai Lifesciences Holdings over the last few years. It is Maravai Lifesciences' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Maravai Lifesciences' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Maravai Operating Cycle Regression Statistics
| Arithmetic Mean | 149.79 | |
| Geometric Mean | 147.64 | |
| Coefficient Of Variation | 18.60 | |
| Mean Deviation | 22.43 | |
| Median | 133.08 | |
| Standard Deviation | 27.86 | |
| Sample Variance | 776.25 | |
| Range | 94.6322 | |
| R-Value | 0.52 | |
| Mean Square Error | 602.97 | |
| R-Squared | 0.27 | |
| Significance | 0.03 | |
| Slope | 2.88 | |
| Total Sum of Squares | 12,420 |
Maravai Operating Cycle History
About Maravai Lifesciences Financial Statements
Investors use fundamental indicators, such as Maravai Lifesciences' Operating Cycle, to determine how well the company is positioned to perform in the future. Although Maravai Lifesciences' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 157.86 | 135.78 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Maravai Lifesciences Correlation against competitors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is there potential for Life Sciences Tools & Services market expansion? Will Maravai introduce new products? Factors like these will boost the valuation of Maravai Lifesciences. Expected growth trajectory for Maravai significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (0.84) | Revenue Per Share | Quarterly Revenue Growth (0.40) | Return On Assets |
Understanding Maravai Lifesciences requires distinguishing between market price and book value, where the latter reflects Maravai's accounting equity. The concept of intrinsic value - what Maravai Lifesciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Maravai Lifesciences' price substantially above or below its fundamental value.
Understanding that Maravai Lifesciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maravai Lifesciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Maravai Lifesciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.